Successful Treatment of Type B Insulin Resistance With Rituximab

CONTEXT: Type B insulin resistance is a very rare disease caused by autoantibodies against the insulin receptor. The mortality of type B insulin resistance is high (>50%), and management of this disease is not yet standardized. We report the successful treatment of a patient with type B insulin r...

Descripción completa

Detalles Bibliográficos
Autores principales: Manikas, Emmanouil-Dimitrios, Isaac, Iona, Semple, Robert K., Malek, Rana, Führer, Dagmar, Moeller, Lars C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2015
Materias:
Special Features
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422897/
https://www.ncbi.nlm.nih.gov/pubmed/25675382
http://dx.doi.org/10.1210/jc.2014-3552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422897/
https://www.ncbi.nlm.nih.gov/pubmed/25675382
http://dx.doi.org/10.1210/jc.2014-3552

Ejemplares similares